Search

everythinglearnresearchcommunity

for

Search:↓

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Zinc can both inhibit and stimulate mouse hair growth, and might help recover hair after chemotherapy.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

New alopecia treatments aim for better results and fewer side effects.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Scalp cooling effectively reduces hair loss from chemotherapy.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Alopecia mucinosa on the face can be linked to mycosis fungoides, a type of lymphoma.

Infertile men are more likely to produce sperm with abnormal chromosome numbers, which can affect pregnancy success and embryo health.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

Bimatoprost is safe and improves eyelash growth in healthy kids but not in those with eyelash loss from chemotherapy or alopecia.

Cedrol may prevent hair loss caused by chemotherapy better than minoxidil.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Cooling can protect hair follicles from chemotherapy damage by reducing drug uptake.

Suppressing eIF4E can prevent hair loss from chemotherapy.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Insurance coverage for scalp cooling will make it more accessible to all chemotherapy patients.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.